Milestone Pharmaceuticals Inc. financial data

Symbol
MIST on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Boul. Dr. Frederik Philips, Ste 420, Montreal, Quebec, Canada
State of incorporation
Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.41K % +8.18%
Debt-to-equity 197 % +258%
Return On Equity -165 % -67.3%
Return On Assets -55.7 % +12.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.3M shares +59.6%
Common Stock, Shares, Outstanding 53.3M shares +59.7%
Entity Public Float 95.9M USD -48%
Common Stock, Value, Issued 288M USD +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 18.6M USD -52.6%
General and Administrative Expense 16.6M USD +0.64%
Operating Income (Loss) -49.3M USD +18.8%
Net Income (Loss) Attributable to Parent -48.4M USD +17.6%
Earnings Per Share, Basic -1.02 USD/shares +26.1%
Earnings Per Share, Diluted -1.02 USD/shares +26.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.3M USD -59.3%
Cash, Cash Equivalents, and Short-term Investments 83.3M USD -4.91%
Assets, Current 87.4M USD -7.62%
Property, Plant and Equipment, Net 222K USD -20.1%
Operating Lease, Right-of-Use Asset 1.65M USD -24.1%
Assets 89.2M USD -8.03%
Employee-related Liabilities, Current 1.42M USD -25%
Liabilities, Current 4.57M USD -32.9%
Operating Lease, Liability, Noncurrent 1.16M USD -33.1%
Liabilities 57.3M USD +1.14%
Retained Earnings (Accumulated Deficit) -346M USD -16.3%
Stockholders' Equity Attributable to Parent 32M USD -20.9%
Liabilities and Equity 89.2M USD -8.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.93M USD +35.7%
Net Cash Provided by (Used in) Financing Activities 32.3M USD -35.7%
Net Cash Provided by (Used in) Investing Activities -27M USD -190%
Common Stock, Shares, Issued 53.3M shares +59.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.63M USD -105%
Deferred Tax Assets, Valuation Allowance 80.2M USD +21.7%
Deferred Tax Assets, Gross 80.2M USD +21.7%
Operating Lease, Liability 2M USD -19.6%
Payments to Acquire Property, Plant, and Equipment 32K USD
Lessee, Operating Lease, Liability, to be Paid 2.28M USD -22.2%
Property, Plant and Equipment, Gross 468K USD +24.1%
Operating Lease, Liability, Current 567K USD +8.62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 670K USD +0.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 673K USD +2.44%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276K USD -37%
Lessee, Operating Lease, Liability, to be Paid, Year Three 530K USD -20.5%
Deferred Tax Assets, Operating Loss Carryforwards 66.7M USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 406K USD -23.4%
Additional Paid in Capital 36.7M USD +26.1%
Depreciation, Depletion and Amortization 28K USD +55.6%
Share-based Payment Arrangement, Expense 7.65M USD -17.8%
Interest Expense 3.39M USD +2542%